The FDA has approved at-home self- or caregiver-administration of FluMist (influenza vaccine live, intranasal).
FluMist’s approval for self- or caregiver-administration provides patients with increased accessibility to the seasonal ...
According to GlobalData, the US vaccination rate for seasonal influenza during the 2023-2024 season was estimated to be 47%, ...
Heart disease is the No. 1 killer of Americans. However, having high LDL-C cholesterol levels doesn’t always lead to heart ...